Article

Beta-Arrestin 1 Mediates Liver Thyrotropin Regulation of Cholesterol Conversion Metabolism…

International Journal of Endocrinology · 2017 · Shaona Niu, author Hui Li, author Wenbin Chen, author Jiajun Zhao, author Ling Gao, author Tao Bo, author Jack Wall, Academic Editor

Key facts

Title Beta-Arrestin 1 Mediates Liver Thyrotropin Regulation of Cholesterol Conversion Metabolism via the Akt-Dependent Pathway
First author Shaona Niu, author Hui Li, author Wenbin Chen, author Jiajun Zhao, author Ling Gao, author Tao Bo, author Jack Wall, Academic Editor
Journal International Journal of Endocrinology
Published Oct 20, 2017
DOI 10.1155/2018/4371396
Devices mentioned BK110039, DEN000008, K022086, K103302
Product codes mentioned JCI, KIP, KIT, NDS, NJT, OOI, PCA

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature